Development asset linked to Hong Kong Baptist in public FDA and regional records.
pharma · Eczema · GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency
Hong Kong Baptist
Hong Kong Baptist University
Hong Kong Baptist drug portfolio — 14 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 18
- Drugs
- 14
- Patents
- 0
Hong Kong Baptist pipeline
Portfolio lens on 14 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Hong Kong Baptist drug portfolio — 14 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Molecular target: Bacterial penicillin-binding protein.
- Target
- Bacterial penicillin-binding protein
- Mechanism
- Bacterial penicillin-binding protein inhibitor
-
US regulatory status: approved. Molecular target: Bacterial 70S ribosome.
- Target
- Bacterial 70S ribosome
- Mechanism
- Matrix metalloproteinase-1 inhibitor
-
exenatide
Alimentary tract and metabolism (A10)Alimentary tract and metabolism (A10) compound in Hong Kong Baptist's portfolio. Molecular target: Glucagon-like peptide 1 receptor.
- Target
- Glucagon-like peptide 1 receptor
- Mechanism
- Glucagon-like peptide 1 receptor agonist
-
Development asset linked to Hong Kong Baptist in public FDA and regional records.
-
Development asset linked to Hong Kong Baptist in public FDA and regional records. Molecular target: Insulin receptor.
- Target
- Insulin receptor
- Mechanism
- Insulin receptor agonist
-
Development asset linked to Hong Kong Baptist in public FDA and regional records.
-
Development asset linked to Hong Kong Baptist in public FDA and regional records.
-
US regulatory status: approved. Molecular target: GABA-A receptor; anion channel.
- Target
- GABA-A receptor; anion channel
- Mechanism
- GABA-A receptor; anion channel agonist
-
Development asset linked to Hong Kong Baptist in public FDA and regional records.
-
Development asset linked to Hong Kong Baptist in public FDA and regional records.
-
Development asset linked to Hong Kong Baptist in public FDA and regional records.
-
Development asset linked to Hong Kong Baptist in public FDA and regional records.
-
Development asset linked to Hong Kong Baptist in public FDA and regional records.